FDA approves first therapy for Alexander disease

• by Kathryn Wighton

• September 4, 2026

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• August 28, 2026

• 5 min

First MCT8 deficiency therapy approved

Clinical studies showed reductions in circulating thyroid hormone levels and changes in heart rate and systolic blood pressure.

• by Kathryn Wighton

• September 29, 2026

• 3 min

Patients engage with epilepsy monitor in real time, improving seizure detection

• October 13, 2026